Mutation analysis of the CHK2 gene in breast carcinoma and other cancers
Open Access
- 1 June 2002
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research
- Vol. 4 (3) , 1-6
Abstract
Mutations in the CHK2 gene at chromosome 22q12.1 have been reported in families with Li-Fraumeni syndrome. Chk2 is an effector kinase that is activated in response to DNA damage and is involved in cell-cycle pathways and p53 pathways. We screened 139 breast tumors for loss of heterozygosity at chromosome 22q, using seven microsatellite markers, and screened 119 breast tumors with single-strand conformation polymorphism and DNA sequencing for mutations in the CHK2 gene. Seventy-four of 139 sporadic breast tumors (53%) show loss of heterozygosity with at least one marker. These samples and 45 tumors from individuals carrying the BRCA2 999del5 mutation were screened for mutations in the CHK2 gene. In addition to putative polymorphic regions in short mononucleotide repeats in a non-coding exon and intron 2, a germ line variant (T59K) in the first coding exon was detected. On screening 1172 cancer patients for the T59K sequence variant, it was detected in a total of four breast-cancer patients, two colon-cancer patients, one stomach-cancer patient and one ovary-cancer patient, but not in 452 healthy individuals. A tumor-specific 5' splice site mutation at site +3 in intron 8 (TTgt [a → c]atg) was also detected. We conclude that somatic CHK2 mutations are rare in breast cancer, but our results suggest a tumor suppressor function for CHK2 in a small proportion of breast tumors. Furthermore, our results suggest that the T59K CHK2 sequence variant is a low-penetrance allele with respect to tumor growth.Keywords
This publication has 24 references indexed in Scilit:
- Analysis of the CHK2 Gene in Lymphoid MalignanciesLeukemia & Lymphoma, 2001
- Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitroProceedings of the National Academy of Sciences, 2000
- DNA Damage-Induced Activation of p53 by the Checkpoint Kinase Chk2Science, 2000
- hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage responseNature, 2000
- Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathwayOncogene, 1999
- Cdc25 Inhibited In Vivo and In Vitro by Checkpoint Kinases Cds1 and Chk1Molecular Biology of the Cell, 1999
- A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphataseCurrent Biology, 1999
- Chromosome 17q-Linkage Seems to be Infrequent in Icelandic Families at Risk of Breast CancerActa Oncologica, 1995
- Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndromeNature, 1990
- Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other NeoplasmsScience, 1990